These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 31526389)
1. Effects of metformin and Exenatide on insulin resistance and AMPKα-SIRT1 molecular pathway in PCOS rats. Tao X; Cai L; Chen L; Ge S; Deng X J Ovarian Res; 2019 Sep; 12(1):86. PubMed ID: 31526389 [TBL] [Abstract][Full Text] [Related]
2. Expression of SIRT1 in the ovaries of rats with polycystic ovary syndrome before and after therapeutic intervention with exenatide. Tao X; Zhang X; Ge SQ; Zhang EH; Zhang B Int J Clin Exp Pathol; 2015; 8(7):8276-83. PubMed ID: 26339397 [TBL] [Abstract][Full Text] [Related]
3. Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats. Xing C; Lv B; Zhao H; Wang D; Li X; He B J Steroid Biochem Mol Biol; 2021 Nov; 214():105992. PubMed ID: 34478829 [TBL] [Abstract][Full Text] [Related]
4. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome. Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098 [TBL] [Abstract][Full Text] [Related]
5. Regulatory effects of the AMPKα-SIRT1 molecular pathway on insulin resistance in PCOS mice: An in vitro and in vivo study. Tao X; Chen L; Cai L; Ge S; Deng X Biochem Biophys Res Commun; 2017 Dec; 494(3-4):615-620. PubMed ID: 28988114 [TBL] [Abstract][Full Text] [Related]
6. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542 [TBL] [Abstract][Full Text] [Related]
7. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway. Zhang S; Tu H; Yao J; Le J; Jiang Z; Tang Q; Zhang R; Huo P; Lei X Reprod Biol Endocrinol; 2020 Jun; 18(1):58. PubMed ID: 32493421 [TBL] [Abstract][Full Text] [Related]
8. Circulating zinc-α2-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment. Zheng S; Liu E; Zhang Y; Long T; Liu X; Gong Y; Mai T; Shen H; Chen H; Lin R; Zheng Y; Xie Y; Wang F Endocr J; 2019 Jun; 66(6):555-562. PubMed ID: 30918134 [TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway. Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999 [TBL] [Abstract][Full Text] [Related]
10. [Effect of Acupuncture on Reproductive Endocrine and p-Akt Protein Expression in Polycystic Ovary Syndrome Rats with Insulin Resistance]. Zhang Y; Cao S; Wen SD; Re ZC; Li YP; Tong L Zhen Ci Yan Jiu; 2018 Oct; 43(10):622-6. PubMed ID: 30365256 [TBL] [Abstract][Full Text] [Related]
11. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome. Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179 [TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S; Akhtar N; Ahmad J Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540 [TBL] [Abstract][Full Text] [Related]
13. Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study. Tao T; Zhang Y; Zhu YC; Fu JR; Wang YY; Cai J; Ma JY; Xu Y; Gao YN; Sun Y; Fan W; Liu W J Clin Endocrinol Metab; 2021 Mar; 106(3):e1420-e1432. PubMed ID: 32995892 [TBL] [Abstract][Full Text] [Related]
14. [Effects of visfatin and metformin on insulin resistance and reproductive endocrine in rats with polycystic ovary syndrome]. Zhang T; Zou X; Su S; Li T; Wan J; Gu J Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1314-8. PubMed ID: 25263366 [TBL] [Abstract][Full Text] [Related]
15. Metformin and sitagliptin combination therapy ameliorates polycystic ovary syndrome with insulin resistance through upregulation of lncRNA H19. Wang Q; Shang J; Zhang Y; Zhou W Cell Cycle; 2019 Oct; 18(19):2538-2549. PubMed ID: 31405334 [TBL] [Abstract][Full Text] [Related]
16. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091 [TBL] [Abstract][Full Text] [Related]
18. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients. Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973 [TBL] [Abstract][Full Text] [Related]
19. Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats. Patel R; Shah G Arch Med Res; 2018 Apr; 49(3):154-163. PubMed ID: 30104075 [TBL] [Abstract][Full Text] [Related]
20. Effects of metformin on endocrine, metabolic milieus and endometrial expression of androgen receptor in patients with polycystic ovary syndrome. Ito-Yamaguchi A; Suganuma R; Kumagami A; Hashimoto S; Yoshida-Komiya H; Fujimori K Gynecol Endocrinol; 2015 Jan; 31(1):44-7. PubMed ID: 25237893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]